Patent · US Active

Compositions and methods of treating retinal disease

US8940764B2 · kind B2 · utility

30Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 26, 2006
Grant dateJan 27, 2015
Priority date
Expiry dateJul 26, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D333/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.